Brief: Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule
08/09/2023 12:49
Sept 8 (Reuters) - Seres Therapeutics Inc MCRB.O :
* SERES THERAPEUTICS REPORTS INDUCEMENT GRANTS UNDER NASDAQ
LISTING RULE 5635(C)(4)
Source text for Eikon: ID:nBwb6Z2FMa
Further company coverage: MCRB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Seres Therapeutics
See all newsChinese automakers make tech-led pitch for Europe's premium car market
Brief: Seres Therapeutics - May Offer Up To $300 Million Of Securities
Seres Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Seres Therapeutics Q2 net income turns positive on VOWST sale gain
Brief: Seres Therapeutics Q2 EPS USD 0.47